Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma

Summary

The study is to observe the efficacy and toxicity of demethylating drug decitabine and cisplatin induced chemotherapy for 3 cycles followed by concurrent chemoradiotherapy in the treatment of regionally advanced nasopharyngeal carcinoma,followed up for 2 years, observing the 2-year survival rate and variation of degrees of methylation before and after treatment,providing clinical basis for the clinical study of stage II-III.

Timeline

Start

2018-02-28

Primary completion

2020-12-01

Completion

2020-12-01

Drugs

Indications